Market Overview:
Levodopa is an amino acid that helps treat the symptoms of Parkinson's disease. It works by restoring the low levels of dopamine in the brain. When combined with carbidopa, it helps reduce side effects and increase the amount of levodopa available to the brain.

Market key trends:
One of the key trends in the levodopa market is the growing focus on gene therapy. Researchers are exploring gene therapies as a potential cure for Parkinson's disease. Some gene therapies aim to protect dopamine neurons from cell death or supplement dopamine production through gene transfer. For example, Axovant is developing AXO-Lenti-PD, a gene therapy that delivers three genes to promote dopamine production and protect neurons. If successful, gene therapies could significantly alter the treatment landscape for Parkinson's disease and reduce the need for levodopa.

The Global Levodopa Market Demand is estimated to be valued at US$ 4.77 Bn in 2023 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis
The global levodopa market is segmented based on route of administration into oral and parenteral. The oral segment currently dominates the market due to convenience of use and cost effectiveness of oral medications. Within the oral segment, levodopa extended release/controlled release formulations are becoming increasingly popular as they reduce dosing frequency and improve patient compliance.

Key Takeaways
The global levodopa market is expected to witness high growth, exhibiting CAGR of 3.4% over the forecast period, due to increasing prevalence of Parkinson's disease globally. According to the Parkinson's Foundation, around 10 million people worldwide are living with Parkinson's disease.

Regional analysis
North America dominates the global levodopa market currently due to high diagnosis and treatment rates in the region. Asia Pacific is expected to exhibit the fastest growth over the forecast period aided by rising healthcare expenditure and presence of large patient population base.

Key players
Key players operating in the levodopa market are Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Mylan N.V., Par Pharmaceutical, Inc., Apotex Inc., Sandoz AG, Dr. Reddy's Laboratories Ltd., and Accord Healthcare Ltd. The global levodopa market is fragmented in nature with these top players accounting for major share.

For more insights, Read-

http://marketerefforts.weebly.com/home/levodopa-market-is-estimated-to-witness-significant-growth-owing-to-rising-geriatric-population